Diurnal Group PLC (LON:DNL) insider Martin Whitaker sold 230,152 shares of the company’s stock in a transaction on Monday, October 21st. The stock was sold at an average price of GBX 26 ($0.34), for a total value of £59,839.52 ($78,190.93).
Martin Whitaker also recently made the following trade(s):
- On Tuesday, August 6th, Martin Whitaker sold 44,810 shares of Diurnal Group stock. The stock was sold at an average price of GBX 37 ($0.48), for a total value of £16,579.70 ($21,664.31).
Shares of DNL stock opened at GBX 28.50 ($0.37) on Tuesday. The business’s fifty day moving average price is GBX 30.56 and its 200 day moving average price is GBX 31.13. Diurnal Group PLC has a 1-year low of GBX 21 ($0.27) and a 1-year high of GBX 57.91 ($0.76). The firm has a market capitalization of $24.12 million and a PE ratio of -1.45.
Diurnal Group Company Profile
Diurnal Group plc operates as a specialty pharma company. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients, as well as adrenal insufficiency.
Recommended Story: What are earnings reports?
Receive News & Ratings for Diurnal Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diurnal Group and related companies with MarketBeat.com's FREE daily email newsletter.